title: Reversible acute renal failure following single administration of fludarabine.
authors.forename: R
authors.initials: R
authors.lastname: Nunes
authors.forename: J L
authors.initials: JL
authors.lastname: Passos-Coelho
authors.forename: N
authors.initials: N
authors.lastname: Miranda
authors.forename: M
authors.initials: M
authors.lastname: Nave
authors.forename: F Leal
authors.initials: FL
authors.lastname: da Costa
authors.forename: M
authors.initials: M
authors.lastname: Abecasis
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D033581:Stem Cell Transplantation; D019172:Transplantation Conditioning / Q000379:methods; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014740:Vidarabine / Q000009:adverse effects* / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014740:Vidarabine; C024352:fludarabine